MedPath

Prospective evaluation of new sedative drug during ESD for esophageal cancer

Not Applicable
Recruiting
Conditions
esophageal cancer
Registration Number
JPRN-UMIN000013159
Lead Sponsor
Department of Gastroenterology, Toranomon Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
104
Inclusion Criteria

Not provided

Exclusion Criteria

1)uncontrollable DM 2)uncontrollable HT 3)uncontrollable heart disease 4)severe or uncontroallable respiratory disease 5)acute alcoholoic addiction 6)epilepsy 7)oxygen is needed in walking or at rest 8)active bacterial of fungal infection 9)pregnancy 10)psychiatric disease 11)alcoholic liver cirrhosis 12)allergy to opistan 13)administered monoamin oxidase inhibitor 14)acute narrow-angle glaucoma 15)myasthenia gravis 16)administered ritonavir

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath